Patent Assignment
Reel/Frame 036136/0181
Change of Name
Recorded: 2015-07-20
Pages: 11
Assignor
DRONE ACQUISITION SUB INC.
Executed: 2015-04-23
Assignee
DENDREON PHARMACEUTICALS, INC.
400 SOMERSET CORPORATE BOULEVARD, BRIDGEWATER, NEW JERSEY, 08807
Covered Properties
(166)
Nucleic Acid Molecules Encoding a Transmembrane Serine Protease 7, the Encoded Polypeptides and Methods Based Thereon
PCT:
PCT/US2002/007903 ↗
Nucleic Acid Molecules Encoding Serine Protese CVSP14, the Encoded Polypeptides and Methods Based Thereon
PCT:
PCT/US2002/009039 ↗
Nucleic Acid Molecules Encoding a Transmembrane Serine Protease 9, the Encoded Polypeptides and Methods Based Thereon
PCT:
PCT/US2002/009611 ↗
Nucleic Acid Molecules Encoding a Transmembrane Serine PROTEASE10, the Encoded Polypeptides and Methods Based Thereon
PCT:
PCT/US2002/015332 ↗
Aromatic Heterocyclic Non-Covalent Inhibitors of Urokinase and Blood Vessel Formation
PCT:
PCT/US2002/038788 ↗
Matriptase Inhibitors and Methods of Use
PCT:
PCT/US2003/040927 ↗
Compositions and Methods Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease
PCT:
PCT/US2004/006979 ↗
Method of Treatment of Hemorrhagic Disease Using a Factor Viia/ Tissue Factor Inhibitor
PCT:
PCT/US2004/013942 ↗
Process for Manufacture of Nematode-Extracted Anticoagulant Protein (Nap)
PCT:
PCT/US2004/015100 ↗
Compositions and Methods for the Treatment of Disease Associated with Trp-P8 Expression
PCT:
PCT/US2004/026931 ↗
Hla-Dr-Specific Antibodies, Compositions and Methods
PCT:
PCT/US2004/042312 ↗
Binding Proteins Specific for Human Matriptase
PCT:
PCT/US2005/045755 ↗
Small-Molecule Modulators of Trp-P8 Activity
PCT:
PCT/US2007/004053 ↗
Promiscuous Her-2/Neu CD4 T Cell Epitopes
PCT:
PCT/US2007/075681 ↗
Promiscuous Pap CD4 T Cell Epitopes
PCT:
PCT/US2007/075704 ↗
Methods for Inducing a Natural Killer (Nk) Cell-Mediated Immunie Response and for Increasing Nk Cell Activity
PCT:
PCT/US2008/003755 ↗
Small-Molecule Modulators of Trp-P8 Activity
PCT:
PCT/US2008/083810 ↗
Humoral Immune Response Against Tumor Antigens After Treatment with a Cancer Antigen Specific Active Immunotherapy and Its Association with Improved Clinical Outcome
PCT:
PCT/US2014/054413 ↗
Reagent for Cell Separation
Patent:
4,927,749 →
Application:
06/849,819 →
Cell Separation Process
Patent:
4,927,750 →
Application:
07/049,863 →
Blood Coagulation Protein Antagonists and Uses Therefor
Application:
07/601,454 →
Hybridoma and Monoclonal Antibody Which Inhibits Blood Coagulation Tissue Factor/Factor Viia Complex
Patent:
5,506,134 →
Application:
07/759,443 →
Trypsin Inhibitors
Application:
07/828,388 →
Bovine Pancreatic Trypsin Inhibitor Derived Inhibitors of Factor Xa
Application:
07/913,232 →
Bovine Pancreatic Trypsin Inhibitor Derived Inhibitors of Factor Viia- Tissue Factor Complex
Application:
07/952,801 →
Asp-Pro-Arg Alpha-Keto-Amide Enzyme Inhibitors
Patent:
5,371,072 →
Application:
07/962,301 →
Novel Inhibitors of Factor Xa
Application:
07/991,204 →
Trypsin Inhibitors
Patent:
5,534,498 →
Application:
08/011,666 →
Novel Neutrophil Inhibitors
Patent:
6,756,211 →
Application:
08/060,433 →
Bovine Pancreatic Trypsin Inhibitor Derived Inhibitors of Factor Viia- Tissue Factor Complex
Patent:
5,807,980 →
Application:
08/086,328 →
Bovine Pancreatic Trypsin Inhibitor Derived Inhibitors of Factor Xa
Patent:
5,747,449 →
Application:
08/086,630 →
N-Sulfonyl Arginine Keto-Amide Compounds
Patent:
5,597,804 →
Application:
08/139,300 →
Novel Neutrophil Inhibitors
Patent:
6,962,795 →
Application:
08/151,064 →
Blood Coagulation Protein Antagonists and Uses Therefor
Application:
08/163,576 →
Novel Inhibitors of Factor Xa
Patent:
5,883,077 →
Application:
08/168,964 →
Method of Detecting Neutrophil Inhibitory Factor Mimics
Patent:
5,747,296 →
Application:
08/173,510 →
Methionine Sulfone and S-Substituted Cysteine Sulfone Derivatives as Enzyme Inhibitors
Patent:
5,776,927 →
Application:
08/229,298 →
Methionine Sulfone and S-Substituted Cysteine Sulfone Derivatives as Enzyme Inhibitors
Patent:
5,681,844 →
Application:
08/234,811 →
Novel Neutrophil Inhibitors
Patent:
5,708,141 →
Application:
08/249,041 →
3-Amino-2-Oxo-1-Piperidineacetic Derivatives as Enzyme Inhibitors
Application:
08/261,378 →
3-Amino-2-Oxo-1-Piperidineacetic Derivatives Containing an Arginine Mimic as Enzyme Inhibitors
Patent:
5,714,499 →
Application:
08/261,498 →
Centrifugation Syringe, System and Method
Patent:
5,577,513 →
Application:
08/298,882 →
Methods for Enriching Breast Tumor Cells
Patent:
5,648,223 →
Application:
08/299,465 →
Methods for Enriching Specific Cell-Types by Density Gradient Centrifugation
Patent:
5,840,502 →
Application:
08/299,467 →
Nethods for Enriching Fetal Cells from Maternal Body Fluids
Patent:
5,646,004 →
Application:
08/299,468 →
Methods for Enriching CD34+ Human Hematopoietic Progenitor Cells
Patent:
5,474,687 →
Application:
08/299,469 →
3-Amino-2-Oxo-Azepine Derivatives as Enzyme Inhibitors
Application:
08/356,831 →
N-Substituted Glycine Derivatives as Enzyme Inhibitors
Patent:
5,696,231 →
Application:
08/361,794 →
Methionine Sulfone and S-Substituted Cysteine Sulfone Derivatives as Enzyme Inhibitors
Patent:
5,658,939 →
Application:
08/423,584 →
Novel Neutrophil Inhibitors
Patent:
6,818,616 →
Application:
08/450,482 →
Modified Hookworm Neutrophil Inhibitors
Patent:
5,919,900 →
Application:
08/450,497 →
Blood Coagulation Protein Antagonists and Uses Therefor
Patent:
5,843,442 →
Application:
08/453,047 →
Trypsin Inhibitors
Patent:
5,714,580 →
Application:
08/455,974 →
Novel Neutrophil Inhibitors
Patent:
5,789,178 →
Application:
08/458,218 →
Arginine Keto-Amide Enzyme Inhibitors
Patent:
5,869,454 →
Application:
08/462,899 →
Novel Inhibitors of Factor Xa
Patent:
5,739,112 →
Application:
08/465,115 →
Methionine Sulfone and S-Substituted Cysteine Sulfone Derivatives as Enzyme Inhibitors
Patent:
5,770,600 →
Application:
08/473,647 →
3-AMIN0-2-Oxo-1-Piperidineacetic Derivatives Containing an Arginine Mimic as Enzyme Inhibitors
Patent:
5,932,733 →
Application:
08/482,117 →
N-Substituted Glycine Derivatives as Enzyme Inhibitors
Patent:
6,025,472 →
Application:
08/484,509 →
3-Amino-2-Oxo-1-Piperidineacetic Derivatives as Enzyme Inhibitors
Patent:
5,703,208 →
Application:
08/484,720 →
Methionine Sulfone and S-Substituted Cysteine Sulfone Derivatives as Enzyme Inhibitors
Patent:
5,646,165 →
Application:
08/485,826 →
Potent Antigen Presenting Cell Composition
Patent:
6,121,044 →
Application:
08/501,987 →
Cell Separation Composition
Patent:
5,789,148 →
Application:
08/570,120 →
Separation Apparatus and Method
Patent:
5,663,051 →
Application:
08/570,397 →
Immunostimulatory Composition and Method
Patent:
6,080,409 →
Application:
08/579,823 →
Cell Washing Device and Method
Application:
08/800,687 →
Growth Arrest Gene Compositions and Methods
Patent:
5,998,599 →
Application:
08/883,070 →
3-Amino-2-Oxo-1-Piperidnercetic Derivatives as Enzyme Inhibitors
Patent:
6,034,215 →
Application:
08/950,270 →
Substituted 3-Amino-2-Hydroxyphenylacetamide Derivatives as Enzyme Inhibitors
Patent:
6,011,047 →
Application:
08/980,114 →
Process for Making Silanized Colloidal Silica
Patent:
6,015,843 →
Application:
09/006,775 →
Blood Coagulation Protein Antagonists and Uses Therefor
Patent:
6,221,659 →
Application:
09/008,121 →
Prostate Tumor Polynucleotide Compositions and Methods of Detection Thereof
Patent:
6,194,152 →
Application:
09/112,096 →
Cell Washing Device and Method
Patent:
6,197,579 →
Application:
09/118,326 →
Title Inhibitors of Urokinase
Patent:
6,576,613 →
Application:
09/121,921 →
Resin Derivatization Method and Uses Thereof
Patent:
6,787,612 →
Application:
09/122,576 →
Immunostimulatory Compositions
Patent:
5,976,546 →
Application:
09/146,283 →
Immunostimulatory Composition
Patent:
6,210,662 →
Application:
09/344,195 →
Inhibitors of Urokinase and Blood Vessel Formation
Patent:
6,432,922 →
Application:
09/359,929 →
Selective Apoptosis of Neoplastic Cells by an Hla-Dr Specific Monoclonal
Application:
09/383,663 →
Plasminogen Activator Inhibitor Antagonists
Patent:
6,638,977 →
Application:
09/444,172 →
Compositions and Methods for Enhancement of Major Histocompatibility Complex Class I Restricted Antigen Presentation
Patent:
7,148,324 →
Application:
09/461,684 →
Inhibitors of Serine Protease Activity of Matriptase or MTSP1
Patent:
6,797,504 →
Application:
09/657,986 →
Plasminogen Activator Inhibitor Antagonists
Patent:
6,677,473 →
Application:
09/716,036 →
Nucleic Acids Encoding Endotheliases, Endotheliases and Uses Thereof
Patent:
7,276,364 →
Application:
09/717,473 →
Nucleic Acid Molecules Encoding Transmembrane Serine Proteases, the Encoded Proteins and Methods Based Thereon
Compositions and Methods for Dendritic Cell-Based Immunotherapy
Novel Non-Convalent Thrombin Inhibitors
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Application:
09/909,164 →
Publication:
US 2002/0068702
Selective Apoptosis of Neoplastic Cells by an Hla-Dr Specific Monoclonal Antibody
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Inhibitors of Serine Protease Activity of Matriptase or MTSP1
Nucleic Acid Molecules Encoding a Transmembrane Serine Protease 7, the Encoded Polypeptides and Methods Based Thereon
Nucleic Acid Molecules Encoding Serine Protease CVSP14, the Encoded Polypeptides and Methods Based Thereon
Nucleic Acid Molecules Encoding a Transmembrane Serine Protease 9, the Encoded Polypeptides and Methods Based Thereon
Method for Determining Potency of Antigenic Presenting Cell Based Vaccines
Nucleic Acid Molecules Encoding a Transmembrane Serine Protease 10, the Encoded Polypeptides and Methods Based Thereon
Aromatic Heterocyclic Non-Covalent Inhibitors of Urokinase and Blood Vessel Formation
Method of Treatment of Hemorrhagic Disease Using a Factor Viia/Tissue Factor Inhibitor
Process for manufacture of nematode-extracted anticoagulant protein (NAP)
Application:
10/440,475 →
Publication:
US 2004/0229334
Matriptase Inhibitors and Methods of Use
Compositions and Methods Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease
Compositions and Methods for the Treatment of Disease Associated with Trp-P8 Expression
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
Application:
10/934,141 →
Publication:
US 2005/0059606
Hla-Dr Specific Antibodies, Compositions and Methods
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Compositions and Methods for Dendritic Cell-Based Immunotherapy
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Application:
11/241,656 →
Publication:
US 2006/0205672
Binding Proteins Specific for Human Matriptase
Process for Manufacture of Nematode-Extracted Anticoagulant Protein (Nap)
Compositions and Methods for Enhancement of Major Histocompatibility Complex Class I Restricted Antigen Presentation
Method of Treatment of Hemorrhagic Disease Using a Factor Viia/Tissue Factor Inhibitor
Small-Molecule Modulators of Trp-P8 Activity
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Process for manufacture of nematode-extracted anticoagulant protein (NAP)
Application:
11/818,324 →
Publication:
US 2008/0221026
Promiscuous Her-2/Neu CD4 T Cell Epitopes
Promiscuous Pap CD4 T Cell Epitopes
Small-Molecule Modulators of Trp-P8 Activity
Methods for Inducing a Natural Killer (Nk) Cell-Mediated Immune Response and for Increasing Nk Cell Activity
Compositions Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease
Nucleic Acid Molecules Encoding Transmembrane Serine Proteases, the Encoded Proteins and Methods Based Thereon
Small-Molecule Modulators of Trp-P8 Activity
Small-Molecule Modulators of Trp-P8 Activity
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
Application:
12/927,372 →
Publication:
US 2011/0105731
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Application:
12/973,020 →
Publication:
US 2011/0117057
Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Patent:
43,298 →
Application:
13/068,159 →
Compositions and Methods for the Treatment of Disease Associated with Trp-P8 Expression
Promiscuous Her-2/Neu CD4 T Cell Epitopes
Methods for Inducing a Natural Killer (Nk) Cell-Mediated Immune Response and for Increasing Nk Cell Activity
Promiscuous Her-2/Neu CD4 T Cell Epitopes
Compositions and Methods for the Treatment of Disease Associated with Trp-P8 Expression
Application:
13/682,151 →
Publication:
US 2013/0190296
Humoral Immune Response Against Tumor Antigens After Treatment with a Cancer Antigen Specific Active Immunotherapy and Its Association with Improved Clinical Outcome
Growth Arrest Gene Compositions
Application:
60/021,874 →
Prostate Tumor Polynucleotide and Antigen Compositions
Application:
60/056,110 →
Selective Apoptosis of Neoplastic Cells by an Hla-Dr Specific Monoclonial Antibody
Application:
60/098,292 →
Compositions and Methods for Enhancement of Major Histocompatibility Complex Class I Restricted Antigen Presentation
Application:
60/112,324 →
Nucleotide and Protein Sequences of Protease Domains of Endotheliase and Methods Based Thereon
Application:
60/166,391 →
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
Application:
60/183,542 →
Plasminogen activator inhibitor antagonists
Application:
60/185,564 →
Compositions and methods for dendritic cell-based immunotherapy
Application:
60/193,504 →
Nucleic acid molecules endcoding transmembrane serine proteases, the encoded proteins and methods based thereon
Application:
60/213,124 →
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
Application:
60/220,101 →
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
Application:
60/220,107 →
Novel peptides as NS3-serine protease inhibitors of hepatitis c virus
Application:
60/220,108 →
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
Application:
60/220,109 →
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
Application:
60/220,970 →
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
Application:
60/234,840 →
Nucleic acid molecules encoding transmembrane serine protease, the encoded proteins and methods based thereon
Application:
60/275,592 →
Nucleic acid molecules encoding transmembrane serine protease 14, the encoded proteins and methods based thereon
Application:
60/278,166 →
Nucleic acid molecules encoding transmembrane serine protease 9, the encoded proteins and methods based thereon
Application:
60/279,228 →
Nucleic acid molecules encoding transmembrane serine protease 10, the encoded proteins and methods based thereon
Application:
60/291,001 →
Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
Application:
60/337,100 →
Matriptase inhibitors and methods of use
Application:
60/436,264 →
Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
Application:
60/453,131 →
Compositions and methods for the treatment of disease associated with TRP-P8 expression
Application:
60/497,384 →
HLA-DR specific antibodies, compositions and methods
Application:
60/608,944 →
High affinity, neutralizing, fully human antibodies to human matriptase
Application:
60/637,859 →
High affinity, neutralizing, fully human antibodies to human matriptase
Application:
60/706,467 →
Small-molecule modulators of Trp-p8 activity
Application:
60/773,435 →
Promiscuous PAP CD4 T cell epitopes
Application:
60/837,053 →
Promiscuous HER-2/Neu CD4 T cell epitopes
Application:
60/837,209 →
Methods for Inducing a Natural Killer (Nk) Cell-Mediated Immune Response and for Increasing Nk Cell Activity
Application:
60/896,461 →
Use of Antigen Spread for Determining Efficacy of Cancer Immunotherapy
Application:
61/874,279 →
Use of Antigen Spread for Determining Efficacy of Cancer Immunotherapy
Application:
61/892,373 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 16, 2015
From: DENDREON CORPORATION, AND ITS WHOLLY OWNED SUBSIDIARIES, DENDREON HOLDINGS, LLC, DENDREON DISTRIBUTION, LLC, AND DENDREON MANUFACTORING, LLC
To: DRONE ACQUISITION SUB INC.
Reel/Frame 036126/0259 →
Security Agreement
Jul 27, 2015
From: DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036190/0503 →
Change of Name
May 3, 2017
From: DENDREON PHARMACEUTICALS, INC.
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 042389/0505 →
Release of Security Interest
Jul 5, 2017
From: BARCLAYS BANK PLC
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 043089/0288 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 042389 Frame: 505. Assignor(S) Hereby Confirms the Change of Name.
Feb 14, 2018
From: DENDREON PHARMACEUTICALS, INC.
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 046088/0882 →